To test our hypothesis, we verified the vulnerability of FTH1‐silenced tumor cells to JQ1, a pan‐BET inhibitor, initially identified as a BRD4 inhibitor, and then, it has been shown to inhibit multiple BET protein members due to the well‐preserved bromodomain sequence [14, 75]. The gene discussed is BRD4; the disease is neoplasm.